Refine by
Drug Discovery Suppliers For Electronics And Computers
216 companies found
based inDresden, GERMANY
PharmAI’s mission is to make early-stage drug discovery far more efficient by increasing success rates while reducing costs. The company develops groundbreaking AI-powered software for the analysis of 3D protein structures. This technology helps ...
pharmAI's innovative solution, which is based on analysing the binding sites, decreases the screening space dramatically. pharmAIs algorithms provide the drug developers with predictions of one or multiple constrained compound space(s) that can ...
based inBern, SWITZERLAND
We want to make organs-on-chip technology the new standard for preclinical decision-making and bring data from bench to clinic. Our organs-on-chip will make drug discovery safer, better and personalized. Our experienced team of biologists, engineers ...
based inCambridge, UNITED KINGDOM
Atelerix was spun out of Newcastle University (UK) in June 2017 by the three co-founders, Professor Che Connon, Dr Steve Swioklo and Dr Mick McLean. The company is commercializing the gel encapsulation approach in two main sectors: Cell models used ...
based inVilligen, SWITZERLAND
InterAx combines machine learning, mathematical modeling of cellular processes, and experimental methods derived from more than 10 years of fundamental research to generate high-efficacy leads for a given GPCR target. We decipher drug effects on ...
Our breakthrough platform combines systems biology, pharmacology, and artificial intelligence to accelerate the hit-to-lead process in GPCR drug discovery. InterAx is setting an industry example of how to better understand the biology of a disease ...
based in, MASSACHUSETTS (USA)
ProXyChem is a Massachusetts (USA) Limited Liability Company established in 2005 by Drs. Sherin S. Abdel-Meguid and Harold V. Meyers to provide cost effective, global drug discovery solutions to the pharmaceutical and biotechnology sectors. ...
ProXyChem’s management, collectively, has over 40 years of drug discovery experience. We provide consulting services in all aspects of the drug discovery ...
based inCambridge, UNITED KINGDOM
Optibrium provides elegant software solutions for small molecule design, optimisation and data analysis, to guide decisions and improve efficiency in drug discovery. Founded in 2009, Optibrium is headquartered in Cambridge, UK with offices in ...
Cerella™ uses a unique deep learning approach to overcome limitations in drug discovery data, reducing costs and accelerating drug discovery cycles. Cerella highlights high-quality compounds with confidence, finding hidden opportunities caused ...
based inChicago, ILLINOIS (USA)
Our company began as Nymirum. As protein drug discovery continued to exhaust low-hanging fruits, we founded Nymirum in 2009 to tackle a new and challenging frontier filled with untapped therapeutic potential: targeting RNA with small molecules. We ...
based inLexington, MASSACHUSETTS (USA)
Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. Through a community of partners, we democratize access to tools, technologies, services, and company creation ...
ATX-Gx™, our first platform, is a royalty-free suite of immunocompetent transgenic mice enabling best-in-class in vivo human antibody discovery. There are three ways to access the ATX-Gx™ ...
based inGermantown, MARYLAND (USA)
VeraChem LLC was founded in 2000 to advance the state of the art in computer-aided drug-discovery and molecular design by developing computational chemistry methods that are based on cutting edge basic science, but are also applicable in applied ...
based inTokyo, JAPAN
Daiichi Sankyo is a global pharmaceutical company with corporate origins in Japan. We provide innovative products and services in 29 countries/regions around the world. With more than 120 years of scientific expertise, our company draws upon a rich ...
based inDaejeon, SOUTH KOREA
We are exploring sequence-based drug discovery and development, which is bypassing the need for 3D structure. ...
DearDTI presents drug candidates with a good efficacy by predicting the binding affinity, based on information about the compound-protein ...
based inStanmore, UNITED KINGDOM
Acellera’s mission is to accelerate the transition to rational, computerized drug discovery via simulations and machine learning. In order to fulfill this vision, we work with our customers by becoming a key technology partner, boosting their ...
PlayMolecule is our platform for computable drug discovery where algorithms, data and computers integrate to discover new ...
based inRiga, LATVIA
Longenesis has created an end-to-end environment for biomedical institutions, patient organizations and research partners and sponsors - to communicate directly, enabling both safe data curation and compliant, consent-enabled biomedical data ...
based inFremont, CALIFORNIA (USA)
AnaSpec, a subsidiary of Kaneka Eurogentec, is a globally recognized biotechnology company that manufactures and sells custom and catalog Peptides, Fluorogenic and FRET Assay Kits, Fluorescent Dyes, Amino Acids and more,? for research use, drug ...
based inOttawa, SWITZERLAND
Orion Biotechnology is unlocking the therapeutic potential of previously undruggable G Protein-Coupled Receptors (GPCRs) with a novel drug modality, proven discovery platform and best-in-class molecules. The company is advancing a diversified ...
G Protein-Coupled Receptors (GPCRs) are involved in a wide range of physiological and pathological processes and represent a large class of drug targets accounting for >30% of all drugs on the market. These drugs, however, only cover 15% of the ...
based inBoston, MASSACHUSETTS (USA)
We can create human tissues and organs using cells from our own bodies, paving the way to make us our own organ donors, reducing organ rejection and solve the problem with lack of donors. We can save lives with faster and more accurate methods for ...
Automated sorting and isolation of single spheroids and organoids. A game-changer in drug screening and other applications where standard 3D models will gradually replace traditional animal models. spheroONE is an innovative single large-particle ...
based inTianjin, CHINA
KMD Bioscience Co., Ltd. specializes in the research & development of Human Drugs. We are an ISO 9001:2015 certified company. We specialize in antibody discovery services, and gradually established stable cell line construction & screening, natural ...
based inParis, FRANCE
Iktos was founded in 2016 by Quentin Perron, Nicolas Do Huu, and Yann Gaston-Mathé, with the aim of developing an innovative and user-friendly technology platform for deep-learning based de novo drug design, leveraging a proprietary algorithm ...
based inSantiago de Compostela, SPAIN
We develop and commercialize new chemical tools to spread the use of fluorescence-based methods in drug discovery. Celtarys is a newly created company focused on the development of innovative chemical tools that improve the efficiency of the High ...
based inCambridge, UNITED KINGDOM
Founded by Dr Mark Kotter and Florian Schuster, bit.bio is an award-winning human synthetic biology enterprise. bit.bio™s mission is coding cells for health. To do so, we apply the principles of computation to biology. Our current focus is to ...